京新药业：2025年前三季度净利润约5.76亿元

Group 1 - The core viewpoint of the article highlights the financial performance of Jingxin Pharmaceutical in Q3 2025, showing a revenue decline but a slight increase in net profit [1] - The company's revenue for the first three quarters of 2025 is approximately 3.048 billion yuan, representing a year-on-year decrease of 5% [1] - The net profit attributable to shareholders is about 576 million yuan, reflecting a year-on-year increase of 0.1% [1] - Basic earnings per share are reported at 0.7 yuan, which is a year-on-year increase of 4.48% [1] Group 2 - As of the report, Jingxin Pharmaceutical has a market capitalization of 15.6 billion yuan [2]